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(57) ABSTRACT 
The present invention provides a method for production of 
functional proteins including hormones by renal cells in a 
three dimensional co-culture process responsive to shear 
stress using a rotating wall vessel. Natural mixture of renal 
cells expresses the enzyme 1-a-hydroxylase which can be 
used to generate the active form of vitamin D: 1,25-diOH 
vitamin D3. The fibroblast cultures and co-culture of renal 
cortical cells express the gene for erythropoietin and secrete 
erythropoietin into the culture supernatant. Other shear 
stress response genes are also modulated by shear stress, 
such as toxin receptors megalin and cubulin (gp280). Also 
provided is a method of treating in-need individual with the 
functional proteins produced in a three dimensional 
co-culture process responsive to shear stress using a rotating 
wall vessel. 
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PRODUCTION OF FUNCTIONAL PROTEINS: 
BALANCE OF SHEAR STRESS AND 
GRAVITY 
RELATED APPLICATIONS 
tained normoglycemia for 18 months in diabetic patients, 
and progressed to Phase I11 clinical trials (4, 10). These 
vessels have also been applied to, for example, mammalian 
skeletal muscle tissue, cartilage, salivary glands, ovarian 
5 tumor cells, and colon crypt cells (11-13). Previous studies 
on shear stress response in endothelial cells, and rotating 
wall vessel culture have been limited to structural genes 
(14-16). These studies did not address the issue of a process 
for the production of functional molecules, such as hor- 
mones. Shear stress response elements have not previously 
been demonstrated in epithelial cells, either for structural 
The jointly made invention described herein was made by genes Of production Of 
an employee of the United States Government and may be Vitamin D dependent rickets has been a disease familiar 
manufactured and used by or for the G~~~~~~~~~ of the to family farms and larger animal husbandry industries for 
therapy by dialysis in humans expanded vitamin D deficient the payment of any royalties hereon or therefor. bone disease from an occasional human clinical caveat to a 
The invention described herein was also made by inven- clinical problem, This led to identification of the 
tors in the performance of work under an agreement with active form of vitamin D as 1, 2 5 - d i 0 ~  D, and the devel- 
Tulane Educational Fund and is subject to the provisions of opment of a multi-billion dollar per year worldwide market, 
Section 305 of the National Aeronautics and Space Act of 20 predominantly in end-stage renal disease patients, to provide 
1958, Public Law 85-568 (72 Stat. 435; 42 U.S.C. 2457). replacement hormone clinically (18). The active 1,25-diOH 
Federal Funding Notice form of vitamin D, is mainly used to treat bone disease in 
The present invention was funded by NIH Grant dialysis patients but has *also been implicated as a therapy 
DK46117, NIH R21, and NASA NRA Grant 9-811. for osteoporosis, and some forms of cancer. Recently, the 
Consequently, the United States government has certain 2s effects of vitamin D have been recognized to play a central 
rights in this invention. role not only in other common bone lesions such as 
osteoporosis due to aging and steroid induced osteoporosis, 
but in immune function and surveillance, growth and 
development, and cardiac and skeletal muscle function 
(1 9-22). 
Several active forms of vitamin D have been identified, 
vitamin D receptors cloned, and nuclear binding proteins for 
the hormone identified and cloned (17-22). Studies on the 
regulation of 1 a-hydroxylase activity are limited by the lack 
of a renal cell line with regulated expression of the enzyme. 
35 The only reports of 1-a-hydroxylase activity in culture 
utilize freshly isolated chicken renal cortical cells in which 
the activity declines precipitously within 48 hours of plating 
in culture (28). 
The Present application claims the benefit of 35 U.S.C. 
§ll l(b) Provisional Patent application 601043,205 filed APr. 
8, 1997. 
10 ORIGIN OF THE INVENTION 
molecules. 
United States OfAmerica for governmental purposes without centuries (17-18). The Of rep1acement 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates generally to the fields of 30 
Protein chemistry, endocrinologY and gene therapy. More 
specifically, the present invention relates to a method for 
production of functional proteins in culture in response to 
shear stress using a rotating wall vessel. 
2. Description of the Related Art 
A successfu~ and documented modality to induce polar- 
ization and differentiation of cells in culture is the rotating 
wall vessel ( 1 4 ) .  In rotating wall vessels gravity is balanced 
stresses, In engineering terms this has been claimed to 40 understood by comparing the kinetics of the renal enzyme to 
other forms in the body (29-30). Demonstration that nephre- simulated microgravity at boundary conditions [Wolf D. A. ctomy in pregnant rats did not completely abolish 1, and R. p. Schwarz. (1991) NASA 25-diOH-D, formation sparked an intensive search for 
Rotating wall vessels, including models with Perfusion, extrarenal sites of 1 a-hydroxylase activity (29). Although 1 
are a quantum advance. The rotating wall vessel is a hori- 45 a-hydroxylase activity has been reported in monocytes, 
zontally rotated cylindrical cell culture device with a coaxial liver, aortic endothelium and a variety of placental and fetal 
tubular oxygenator (1,5-7). The rotating wall vessel induces tissues, the enzyme kinetics contrast sharply with the renal 
expression of select tissue-specific proteins in diverse cell 1 a-hydroxylase. Extrarenal 1-a-hydroxylase has a much 
cultures (1-2, 8-9). Examples of expression of tissue- higher Km indicating that much higher substrate levels are 
specific proteins include carcinoembryonic antigen expres- 50 needed for activity (29). In the uremic patient, extrarenal 
sion in MIP-101 colon carcinoma cells (2), prostate specific 1,25-diOH D, production is very limited due to a relative 
antigen induction in human prostate fibroblasts (7), through lack of substrate. Administrating large quantities of 25-OH 
matrix material induction during chondrocyte culture (8). D, substrate to anephric patients modestly boosts plasma 
The quiescent cell culture environment of the rotating wall 1,25-diOH D, levels (29). 
obvious mass transfer tradeoff (1-2, 4). The rotating wall epithelial cells for investigative purposes persists despite 
vessel Provides a culture environment suitable for extensive searches by several laboratories (31-38). Renally 
Co-cultures of diverse cell types, and three dimensional derived cell lines transformed with viruses or tumor cells to 
tissue construct formation. produce immortality continue as some of the most popular 
Rotating wall vessel technology is being used in clinical 60 cell biological tools to study polarized delivery (31,33,35). 
medical practice recently by facilitating pancreatic islet But these renally derived immortal cell lines such as MDCK 
implantation (4, 10). Pancreatic islets are prepared in rotat- or LLP-CK1 retain few if any of the differentiated features 
ing wall vessels to maintain production and regulation of characteristic of renal epithelial cells. Similarly, primary 
insulin secretion. The islets are alginate encapsulated to cultures rapidly dedifferentiate and modalities as diverse as 
create a non-inflammatory immune haven, and are 65 basement membrane matrices, growth supplements or Mil- 
implanted into the peritoneal cavity of Type I diabetic lipore inserts achieve only modest degrees of polarity 
patients. This implantation of pancreatic islets has main- (37-38). 
by equal and opposite physical forces including shear The importance Of the l-a-hydroxylase is best 
Paper 31431. 
vessel balances gravity with shear and other forces without 5s The lack of a differentiated polarized line of renal tubular 
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The pathognomonic structural features of renal proximal 
tubular epithelial cells are the abundance of apically derived 
microvilli, the glycoprotein content of associated intermi- 
crovillar clefts, and the highly distinctive arrangement of 
In yet another embodiment of the present invention, there 
is provided a transcription factor decoy, comprising an 
oligonucleotide sequence directed. against a nucleotide 
sequence encoding a shear stress response element, 
endosomal (39-40). 5 Other and further aspects, features, and advantages of the 
present invention will be apparent from the following 
description of the presently preferred embodiments of the 
invention given for the purpose of disclosure, 
cells of the proximal tubule are characterized by thousands 
begins in intermicrovillar clefts. The endosomal pathway is 
characterized by clathrin coated vesicles, small spherical 
endosomal vesicles, with deeper larger endosomal vacuoles 10 
(33, 39). From the endosomal vacuoles proteins and lipids 
either recycle to apical surface in dense apical tubules or 
shuttle to lysosomes to be degraded. 
A cluster of apical proteins with homologous sequence 
repeats are especially desirable to express in cultured cells as is 
(41-43). Of these proteins megalin (gP330) and cubulin 
(gp280) (Moestrup2 e t  J .  Bioz. Chem.f1273 
(9):5325-5242 (1998) are molecular mediators of tubular 
of 10% apical microvilli. The apical endosoma1 machinery 
BRIEF DESCRIPTION OF THE DRAWINGS 
The file of this patent contains at least one drawing 
executed in color, Copies of this patent with color drawing 
(s)  will be provided by the Patent and Trademark Office 
upon request and payment of the necessary fee, 
so that the matter in which the above-recited features, 
which will become clear, are attained and can be understood 
in detail, more particular descriptions of the invention 
briefly summarized above may be had by reference to 
they are thought to be mediators Of injury advantages and objects of the invention, as well as others 
and ensuing secondary Megalin 20 certain embodiments thereof which are illustrated in the 
specification, It is to be noted, however, that the appended 
drawings illustrate preferred embodiments of the invention 
and therefore are not to be considered limiting in their scope, 
FIGS. 1(A-D) shows homogeneity and structure of 
human renal epithelial cells in culture. Flow cytometry 
frequency histograms demonstrate number of cells positive 
for the proximal tubular marker y-glutamyl transferase. 
with y-glutamyl 
transferase activity as the frequency of activity in 2000 cells 
This is the raw digest Of human 
(@330) is a receptor found On the lumina' 'IKface Of the appended drawings, These drawings form a part of the 
proximal 
proteins and drugs including aminoglycoside antibiotics and 
Other polybasic drugs. Megalin is expressed in the kidney, 
lung, testes, ear, and placenta. The only cells which express 2s 
megalin in culture are immortalized placental cells. There is 
no known renal cell culture which expresses megalin. 
Gp280 is a receptor found on the luminal surface of the 
proximal tubular cells of the kidney. Gp280 binds several 
proteins and drugs including intrinsic factor-cobalamin 30 
(vitamin B12 bound to its carrier protein) and myeloma light 
placenta. The only cells which express cubulin (gp280) in 
culture are immortalized placental cells. There is no known FIG. 1B shows that following differential trypsinization, 
renal cell culture which expresses cubulin (gp280). 35 the percentage of proximal tubular cells present can be 
Erythropoietin (EPO) is a hormone produced in the increased to 99+1'%. 
kidney, and secreted into the blood. Erythropoietin controls FIGS. 1c and 1D show transmission electron micro- 
the rate of production of red blood cells by the bone marrow. graphs of human epithelial cells in culture. The intact renal 
Erythropoietin may be produced by the interstitial cells cortex in Vivo (far left Panel), is compared to culture of the 
between the tubules or the proximal tubular cells or both. 40 natural mixture of human renal cortical cells in conventional 
Erythropoietin production is lost in all known renal cell 2-dimensional culture (middle left panel) which is com- 
culture systems, Erythropoietin is mainly used to treat pletely devoid of microvilli. Rotating wall vessel culture of 
anemia in dialysis patients but is also popular to treat the pure proximal tubular cells shows some microvilli (middle 
Of the kidney. Megalin binds 
lA shows the number Of 
chains. Cubulin (gp280) is expressed in the kidney, ear, and to an unstained with trapping agent 
anemia of AIDS patients and many forms of cancer. 
ne prior art is deficient in the lack of effective 
producing functional proteins including hormones in 
response to shear stress, Further, the prior art is deficient in 
the identification of shear stress response elements in epi- 
thelia1 cell genes. The present invention fulfills this long- 
standing need and desire in the art. 
right panel) but there are far more microvilli during rotating 
of 45 wall vessel culture of the natural mix of renal cortical cells 
(far right Panel). Compared to these representative images, 
some areas of the natural mixture of cells in the rotating wall 
vessel show much greater abundance of microvilli, and well 
defined desmosomes (lower Panel) which are lacking in the 
FIG. 2 shows protein expression in the rotating wall 
vessel. FIGS. 2A-2C show analysis of the expression and SUMMARY OF THE INVENTION 
In one embodiment of the present invention, there is endosomal compartmentation of megalin, and cubulin in 
provided a method of producing a functional protein, com- renal cells following rotating wall vessel culture. The ability 
prising the steps of: isolating mammalian cells; placing said ss of flow cytometry to make simultaneous measurements of 
comprising culture media and culture matrix; producing antibody binding allows construction of three dimensional 
50 other cultures. 
cells into a rotating wall vessel containing a cell culture entrapped fluorescein dextran as an endosoma1 marker and 
three-dimensional cell aggregates under simulated micro- frequency histograms displaying entrapped fluorescein dex- 
gravity conditions; and detecting expression of the func- tran fluorescence against antibody binding on horizontal 
tional protein in the cell culture. 60 axes. A control sample shows vesicles negative for fluores- 
In another embodiment of the present invention, there is cein on the left and fluorescein containing endosomes on the 
provided a method of inducing expression of at least one right (2000 vesicles depicted left panel). A control without 
gene in a cell, comprising the steps of  contacting said cell fluorescein entrapped shows only the left population (not 
with an transcription factor decoy oligonucleotide sequence shown). Co localization of anti-cubulin binding demon- 
directed against a nucleotide sequence encoding a shear 65 strates that all the fluorescein positive endosomes are posi- 
stress response element; and determining the expression of tive for cubulin, while non-endosomal membranes can be 
said gene in said cell. subdivided into cubulin positive and negative populations 
US 6,730,498 B3 
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(middle panel). This pattern is repeated for anti-megalin 
binding in renal cortical cells (right panel). 
FIG. 2B shows quantitation of cubulin, and megalin 
antibody binding to renal cell membranes under various 
culture conditions. Analysis of protein expression in cul- 
tured cells by antibody binding used classic serial log 
dilution antibody curves. An increase in binding with a 
decrease in dilution is pathognomonic for specific antibody 
binding during flow cytometry analysis. Binding of anti- 
cubulin antisera to membrane vesicles prepared from renal 
cortical cells after 16 days in culture, detected by the 
fluorescence of a phycoerthyrein tagged secondary antibody, 
shows an almost two log increase in binding with antibody 
dilution (upper left panel below). This increased cubulin 
antibody binding in the cells grown in the rotating wall 
vessel (STLV) is more than five times the expression seen in 
stirred fermentors. Similarly, there was no detectable expres- 
sion in the conventional cultures resulting in a flat line (not 
shown). Binding of normal serum and minimal dilution of 
primary antisera were not detectably different. Binding 
curves for anti-megalin antiserum showed a similar pattern 
(not shown). 
FIG. 2C depicts non-specific (minimum) and peak bind- 
ing of each antiserum following rotating wall vessel culture 
and two-dimensional SDS-PAGE analysis of protein content 
of cells following rotating wall vessel culture. Analysis of 
the protein content of cultures of the natural mixture of rat 
renal cortical cells after 16 days culture in gas permeable 
bags as a control (left panel) or rotating wall vessel (right 
panel) depicts changes in a select set of proteins. Molecular 
weight (14-220 kDa) on the abscissa is displayed against 
isoelectric point (PH 3-10) on the ordinate. 
FIGS. 3(A-D) shows gene expression in the rotating wall 
vessel. FIG. 3A and FIG. 3B show differential display of 
genetic expression of rat renal cortical cells grown in 
conventional culture or rotating wall vessels. Differential 
display of expressed genes was compared in aliquots of the 
same cells grown in a 55 ml rotating wall vessel (STLV) or 
conventional gas permeable 2-dimensional bag controls. For 
differential display, copies of expressed genes were gener- 
ated by polymerase chain reaction using random 25 mer 
primers and separated on a 6% DNA sequencing gel (FIG. 
3A). Bands of different intensity between control and STLV, 
representing differentially expressed genes, were identified 
by visual inspection, excised and reamplified using the same 
primers. Differential expression and transcript size were 
confirmed by Northern hybridization (FIG. 3B). PCR prod- 
ucts were then subcloned into the pGEM-T vector and 
sequenced. Sequences were compared to the Genebank 
sequences using the BLAST search engine. One expressed 
gene which decreased in the STLV (band D on gelabove) 
was identified as rat manganese-containing superoxide dys- 
mutase (98% match 142 of 144 nucleotides). Two genes 
which increased in the STLV, band A was identified as the 
interleukin-1 beta gene (100% match for 32 of 32 
nucleotides) and Band B which corresponded to a 20 kB 
transcript on a Northern blot appears to be a unidentified 
gene that has a 76% homology to the mouse GABA trans- 
porter gene. FIG. 3C and FIG. 3D show RT-PCR of time 
dependent change in genes during rotating wall vessel 
culture. Semi quantitative RT-PCR shows increases in the 
epithelial genes megalin, villin and extra-cellular calcium 
sensing receptor (ECaR), the shear stress response element 
genes ICAM, VCAM and MnSOD (FIG. 3C). There was no 
change in b-actin or GADPH. Unlike in endothelial cells 
many of these changes are prolonged as at 16 days megalin, 
ECaR, ICAM, VCAM and villin changes persist (FIG. 3D). 
6 
FIG. 4Ashows structure and effects of antisense probe for 
shear stress response element on rat renal cortical epithelial 
cells. FIG. 4Ashows the structure. The probe with sequence 
CTGAGACCGATATCGGTCTCAG (SEQ ID No:l) has 
s two possible conformations. As a single strand it would fold 
back on itself to form a binding element for the transcription 
factor. As a double strand it would then have two binding 
sites for the transcription factor, one in the sense orientation 
and one in the antisense orientation. 
FIG. 4B shows effects of antisense shear stress response 
element probe on time dependent gene expression. The 
antisense probe added to conventional 2-dimensional cul- 
tures of rat renal cortical cells at 80 nm increases MnSOD 
in a time dependent manner. Comparison is made to controls 
15 with the active binding site scrambled. In contrast the probe 
has no effect on villin gene expression. 
FIG. 5 shows gene expression in the rotating wall vessel: 
automated gene analysis. Abundance of the expression of 
over 18,300 genes was assayed by annealing poly A RNA 
2o from human renal cortical epithelial cells grown in a rotating 
wall vessel for 8 days to a filter robotically loaded with 
oligonucleotide primers. Poly A RNA from a non adherent 
bag culture serves as a control. The filters are shown at the 
top of the diagram then the analysis of shear stress respon- 
25 sive genes, renal epithelium specific genes, and other genes 
germane to the current analysis. 
10 
DETAILED DESCRIPTION OF THE 
INVENTION 
30 
The present invention is directed to a method of produc- 
ing a functional protein, comprising the steps of  isolating 
mammalian cells; placing said cells into a rotating wall 
vessel containing a cell culture comprising culture media 
35 and culture matrix; producing three-dimensional cell aggre- 
gates under simulated microgravity conditions; and detect- 
ing expression of the functional protein in the cell culture. 
Generally, simulated microgravity conditions comprise a 
balance between gravity and oppositely directed physical 
4o forces. Representative examples such physical forces 
include sedimentational shear stress, centrifugal forces, vis- 
cosity and coriolus forces. 
Preferably, the functional protein is selected from the 
group consisting of a hormone, a toxin receptor and a shear 
45 stress dependent functional biomolecule. Representative 
examples of hormones which can be produced according to 
the method of the present invention include 1,25-dihydroxy- 
vitamin D3 and erythropoietin. Representative examples of 
toxin receptors which can be produced according to the 
50 method of the present invention include megalin and cubu- 
lin. Representative examples of shear stress dependent func- 
tional biomolecule which can be produced according to the 
method of the present invention include is selected from the 
group consisting of villin, magnesium dependent superoxide 
55 dismutase, nitric oxide synthase, c-fos, c-jun, platelet 
derived growth factor-b, transforming growth factor-b, 
tissue-type plasminogen activator and monocyte chemotac- 
tic protein- 1, megalin, cubulin, erythropoietin and 1 
-a-hydroxylase. 
Generally, any mammalian cell could be used in the 
methods of the present invention. Representative examples 
of mammalian cells include renal cortical cells, renal fibro- 
blast cells, hepatocytes, pancreatic islets, renal interstitial 
cells, parathyroid cells, thyroid cells, pituitary cells, ovarian 
65 cells and testicular cells. Generally, the cell is selected from 
the group consisting of epithelial cell and endothelial cell. 
Preferably, cell contains shear stress response elements. 
60 
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Representative examples of shear stress response element 
include GAGACC and GGTCTC. 
In the methods of the present invention, the rotating wall 
vessel is initiated and maintained from about 6 rotations per 
minute to about 16 rotations per minute. Preferably, the 
sedimentational shear stress is from about 0.2 dynesicm2 to 
about 1.0 dynesicm2. The culture matrix may contain a core 
structure selected from the group consisting of cell aggre- 
gates and microcarrier beads, although other components to 
such a culture matrix are well known to those having 
ordinary skill in this art. 
The present invention is also directed to a method of 
inducing expression of at least one gene in a cell, comprising 
the steps of  contacting said cell with an transcription factor 
decoy oligonucleotide sequence directed against a nucle- 
otide sequence encoding a shear stress response element; 
and determining the expression of said gene in said cell. 
Generally, oligonucleotide comprises a terminal phospho- 
thiorate moiety and a phosphodiester backbone and a struc- 
ture which allows the oligonucleotide to pass cell mem- 
branes and accumulate in the nuclear compartment of the 
cell. Generally, the cell is a cultured cell. Preferably, the cell 
is selected from the group consisting of an epithelial cell and 
an endothelial cell. Representative examples of which can be 
used in this method include renal cortical cell, renal fibro- 
blast cell, hepatocyte, pancreatic islet, renal interstitial cell, 
parathyroid cell, thyroid cell, pituitary cell, ovarian cell and 
testicular cell. In one embodiment, the cell is grown in two 
dimensional culture. Representative examples of shear stress 
response elements include GAGACC and GGTCTC. 
Preferably, the gene encodes a protein selected from the 
group consisting of megalin, cubulin, erythropoietin and 
l-a-hydroxylase. The concentration of the oligonucleotide 
useful in this method generally ranges from about 10 nm to 
about 10 mm. 
The present invention is also directed to a transcription 
factor decoy, comprising an oligonucleotide sequence 
directed against a nucleotide sequence encoding a shear 
stress response element. Preferably, the nucleotide sequence 
encoding a shear stress response element has a sequence 
selected from the group consisting of GAGACC and 
GGTCTC. 
In one preferred technique, the rotating wall vessel is 
generally initiated and maintained at 10 rotations per 
minute. Preferably, the rotating wall vessel provides a bal- 
ance of forces comprising gravity and equal and opposite 
sedimentational shear stress. Useful sedimentational shear 
stress rates within the context of the claimed methods are 
from about 0.2 dynesicm2 to 1.0 dynesicm2. 
As used herein, rotating wall vesselscrefers to a cylidrical 
horizontal rotating culture vessel with a coaxial oxygenator. 
As used herein, shear stress response elementcrefers to a 
sequence of a family of genes in the cell nucleus which binds 
one or more transcription factors in response to shear stress 
on the cell. A representative example of a shear stress 
response element is GAGACC or its complementary 
sequence GGTCTC. 
As used herein, shear stress conditionscrefers to flow of 
liquid, or current of liquid over cells which causes genes to 
turn on or off. 
As used herein, slow turning lateral vesselcrefers to one 
specific size and shape of a rotating wall vessel. 
As used herein, differential displaycrefers to displaying 
on a filter, gel or chip a discrete set of genes turned on or off 
in a cell under two different conditions. 
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As used herein, simulated microgravitycrefers to balance 
of gravity by oppositely directed forces including shear 
stresses during rotational wall vessel culture. 
As used herein, graded gravitational sedimentation 
shearcrefers to the shear imparted to a particle or cell falling 
through fluid. 
As used herein, functional proteincrefers to a protein with 
biological effects. 
A s  used herein,  three-dimensional  co-cul ture  
processcrefers to cells grown in a matrix or on beads (or 
other three-dimensional structural suport) in a three- 
dimensional array, rather than on a flat plate. 
As used herein, coriolus forcecrefers to an incidental flow 
field caused by the rotating gravity vector in the rotating wall 
vessel. 
As used herein, shear stresscrefers to the force felt at the 
surface of the particle as it moves through the fluid. 
As used herein, gravity induced sedimentationcrefers to 
the force on a particle in the rotating wall vessel making it 
fall through the fluid due to gravity. 
As used herein, centrifugal forcecrefers to the force on a 
particle in the rotating wall vessel which pulls it towards the 
wall due to rotational speed. 
As used herein, transcription factor decoycrefers to an 
oligonucleotide folded to form a double stranded DNA 
which binds a nuclear trancription factor. The transcription 
factor decoy prevents the transcription factor from binding 
promoter regions regulating expression of specific genes. 
The following examples are given for the purpose of 
illustrating various embodiments of the invention and are 
not meant to limit the present invention in any fashion. 
EXAMPLE 1 
Human Renal Cortical Cells 
Human renal cortical cells were isolated by Clonetics Inc. 
(San Diego, Calif.) from kidneys unsuitable for transplan- 
tation. Differential trypsinization resulted in cell fractions 
highly purified for proximal tubular cells compared to the 
natural mixture of cells in the renal cortex. The co-culture of 
the natural cell mix, and highly purified proximal tubular 
cells were cultured separately in a special growth medium 
with 2% fetal calf serum. 
EXAMPLE 2 
Rat Renal Cortical Cells 
Rat renal cells were isolated from renal cortex harvested 
from euthenized Sprague Dawley rats (Harlan Sprague- 
Dawley, Cleveland Ohio) as described (44). In brief, renal 
cortex was dissected out with scissors, minced finely in a 
renal cell buffer 137 mmol NaC1, 5.4 mmol KC1, 2.8 mmol 
CaC12, 1.2 mmol MgC12, 10 mmol HEPES-Tris, pH 7.4. 
The minced tissue was placed in 10 ml of a solution of 0.1% 
Type IV collagenase and 0.1% trypsin in normal saline. The 
solution was incubated in a 37" C. shaking water bath for 45 
minutes with intermittent titration. The cells were spun 
gently (800 rpm for 5 minutes), the supenatant aspirated, the 
cells resuspended in 5 ml renal cell buffer with 0.1% bovine 
serum, and passed through a fine (70 mm) mesh. The 
fraction passing through the mesh was layered over a 
discontinuous gradient of 5% bovine serum albumin and 
spun gently. The supernatant was again discarded. The cells 
were resuspended in DMEMF-12 medium (ciprofloxacin 
and fungizone treated) and placed into culture in various 
culture vessels in a 5% C 0 2  95% 0 2  incubator. 
US 6,730,498 B1 
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EXAMPLE 3 to each cell culture for 10 minutes at 37" C. in the C 0 2  
Culture Techniques: Rotating Wall Vessels incubator. This loads an entrapped fluorescent dye into the 
When grown under conventional conditions in DMEMi early endosomal pathway (9, 47). Cells were then immedi- 
F12 supplemented with fetal calf serum and an antibiotic ately diluted into ice cold phosphate buffered saline and 
cocktail such as ciprofloxacin and fungizone, both the highly s washed once. Next, the cells were homogenized with 6 
purified cells as well as the cell mix form a monolayer. Fetal passes of a tight fitting glass-Teflon motor driven homog- 
calf serum was used at optimal concentration: 2% for human enizer. Apost-nuclear supernatant was formed as the 11,000 
cells and 10% for rat cells. In order to increase epithelial cell g supernatant, 180,000 g pellet of membrane vessels (FIGS. 
differentiation (1,45), renal cells were cultured in a rotating 2A-2C). 
wall vessels known as a 55 ml slow turning lateral vessel i o  Aliquots of membrane vesicles were labeled with megalin 
(STLV) (1, 45). To initiate cell culture, the slow turning or cubulin antisera. The megalin and cubulin antisera were 
lateral vessel was filled with medium, and seeded by addi- rabbit polyclonals raised to affinity purified and chromato- 
tion of cell suspension (2x106 cellsiml). Residual air was graphically pure receptor (43,48). Membrane vesicles were 
removed through a syringe port and vessel rotation was first pre-incubated in 50% normal goat serum for 2 hours to 
initiated at 10 rotations per minute, and maintained for is reduce non-specific binding of secondary antisera raised in 
10-16 days. Medium was changed every 2 to 3 days goat. After washing aliquots of membrane vesicles were 
depending on glucose utilization. Concomitant with cells, stained with serial log dilution of antisera and incubated at 
microcarrier beads were added an 5 mgiml to promote 4" C. overnight. After further washing 1:40 of goat anti- 
aggregate formation in the slow turning lateral vessel. With- rabbit affinity purified rat pre-absorbed phycoerthyrein con- 
out beads the cells became shattered in the vessel in a few 20 jugated secondary antiserum was added, and incubated for 4 
hours. Beads were cytodex-3 in all protocol except when hours at room temperature. Prior to flow cytometry the 
electron microscopy was planned when the much more membrane vesicles were washed and resuspended in 200 
expensive, but easily sectioned Cultisphere GL cells were mM mannitol, 100 mM KC1, 10 mM HEPES, pH 8.0 with 
added to the vessels. Tris to which had been added 10 mM nigericin. In the 
zs presence of potassium, nigericin collapses pH gradients, 
ensuring optimal fluorescence of the highly pH dependent 
fluorescein-dextran emission. Fluorescein-dextran and anti- 
body staining tagged by phycoerythrein were now analyzed 
and co-~oca~ized on a vesic~e-by-vesic~e basis by flow 
EXAMPLE 8 
EXAMPLE 4 
Stirred Controls and Static Controls 
To provide a stirred control stirred fermentors which 
mixed in the horizontal plane were loaded with identical 
concentrations of cells and beads from the same pool added 3o cytometry (FIG, 213). 
to the slow turning lateral vessel (1, 31,46). Gas permeable 
Fluoroseal bags (Fluoroseal Inc, Urbana Ill.) in 7 or 55 ml 
size were selected as conventional static controls. Culture 
beads were added to the conventional controls at the same Differential display of expressed genes was compared in 
density as the slow turning lateral vessel cultures (1, 45). 
vessel (slow turning lateral vessel) or conventional gas 
EXAMPLE 5 permeable 2-dimensional bag controls (FIGS. 3A and 3B). 
Electron Microscopy Quantitation of Number of Microvilli Differential display was performed using Delta RNA Fin- 
Transmission electron micrographs were performed on gerprinting system (Clontech labs, Palo Alto Calif.). Copies 
cell aggregates from the rotating wall vessels and conven- of expressed genes were generated by polymerase chain 
tional monolayers. Cells were washed with ice cold phos- reaction using random 25 mer primers and separated on a 
phate buffered saline, then fixed for electron microscopy 6% DNA sequencing gal. Bands of different intensity 
with 2.5% glutaraldehyde in phosphate buffered saline (9, between control and slow turning lateral vessel, representing 
47). The samples were then transferred to 1% osmium differentially expressed genes, were identified by visual 
tetroxide in 0.05 M sodium phosphate (pH 7.2) for several inspection, excised and reamplified using the same primers. 
hours, dehydrated in an acetone series followed by embed- Differential expression and transcript size were confirmed 
ding in Epon. Lead-stained thin sections were examined and by Northern hybridization. PCR products were then sub- 
photographed using a Phillips EMROO electron microscope. cloned into the pGEM-T vector (Promega, Madison Wis.) 
For electron microscopy the easily sectioned Cultispere GL and sequenced using fMOL cycle sequencing system 
beads, replaced Cytodex-3 which is almost impossible to (Promega, Madison, Wis.). Sequences were compared to the so section. Genebank sequences using the BLAST search engine 
(National Center for Biotechnology Information). For genes 
of interest the bands were labeled with 32P for confirmation 
of the changes by Northern blot analysis, 
3s aliquots Of the Same grown in a 55 m1 rotating 
40 
4s 
EXAMPLE 6 
Analysis of the Proximal Tubule Epithelial Marker, 
g-glutamyl Transpeptidase 
tubules as determined by flow cytometry analysis of aliquots 
for the proximal marker g-glutamyl transferase using Schiff 
base trapping of cleavage products of L-g-glu-4-methoxy- 
4-b-naphthylamine (44) (FIG. 1). 
The renal cortical cells were 75+4% (n=4) proximal 5s EXAMPLE 9 
Detection of Gene Expression in Cell Cultures by RT-PCR 
Cell aggregates from the rotating wall vessel culture were 
washed once in ice cold phosphate buffered saline and snap 
frozen at -70" C. until RNA was isolated. Total RNA was 
60 first isolated, followed by isolation of poly A+ RNA. Fol- 
EXAMPLE 7 lowing reverse transcription, 10%-20% of each cDNA was 
Analysis of the Endosomal Distribution of Megalin and amplified (Robocycler 40, Stratagene, La Jolla, Calif.) using 
Cubulin by Flow Cytometry 95" C. denaturation, 63" C. annealing and 72" C. extension 
To quantitate the total and endosomal expression of temperatures. Amplification was for a total of 30 cycles with 
cubulin, megalin and aquaporin-2 cells in conventional 65 the first three cycles having extended denaturation and 
culture, stirred fermentors and slow turning lateral vessel annealing times. Positive and negative strand PCR primers, 
rotating wall vessels, 0.3 mgiml10S fluorescein-dextran was respectively, were derived from published sequences using 
US 6,730,498 B1 
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Generunner software. 20% of the PCR reaction was elec- 
trophoresed on agaroseiethidium bromide gels and visual- 
ized under UV light so that a comparison of amplified gene 
x174 DNA, Promega) electrophoresed on the Same gel 
anti-oxidant DPED at 10 mM to ensure no contribution of 
non-enzymatic oxygenation (23-26). 1,25-diOH D3 gener- 
ated in vitroflwas quantitated as described (23-27). In 
acetonitrile equal to the incubation volume. Each incubation 
tube received 1,000 cpm of 3H-1,25 dihydroxy D3 to 
fragments could be made to DNAstandards (HaeIII digested 
3c and 3D). Representative fragments amp1ified for 
each gene in question were isolated from gels and direct 
vitroflincubations were terminated by adding a Of 
estimate recovery losses during the extensive extraction and 
purification scheme, The 1,25-dihydroxy D3 is extracted 
sequenced to assure identity of the PCR product. In addition, from the incubation medium by c18 solid-phase extraction 
5% ofthe Same cDNAwere subjected to PCR for expression (24-25). Following extraction, the samples are evaporated to 
of the housekeeping MRNA, glyceraldehyde 3-phosphate i o  dryness under N2 and dissolved in 2 ml of methylene 
dehydrogenase, and b-actin to assure that similar amounts of chloride. The samples are then applied to silica Bond-Eht 
input RNA and that similar of transcrip- cartridges and the 1,25-dihydroxy D3-containing fraction is 
tion were being ~~~h c~~~ was run in at least isolated and collected (26). The individual fractions con- 
HPLC on a Beckman model 344 liquid chromatography 
system. Normal-phase HPLC was performed with a Zorbax- 
Si1 column (26) (4x25 cm) developed in and eluted with 
methylene chlorideiisopropanol (96:4 viv) with a flow rate 
was dried under N2 resuspended in ethanol and quantitated 
2o by radio receptor assay or radio immunoassay (25-26). 
Plasma 1-25-dihydroxy vitamin D3 was assayed in a similar 
fashion, but as the product is already formed, assay begins 
three dilutions to ensure that measurements were made on taining 1, 25-di0H D3 and then subjected to phase 
the initial linear portion of the response curve. 1s 
EXAMPLE 10 
Genetic Decoys 
a known shear stress response element were synthesized 
(Chemicon International Inc., La Jolla, Calif.) (structure and 
sequence shown at top Of 4)' These decoys had a 
Double stranded genetic decoys matching the sequence of Of mlimin. The 1,25-dihydroxy D3 from this system 
phosphothiorate moiety to prevent with extraction into acetonitrile (23-26). Hence, all mea- 
surement of l-a-hydroxylase activity in cells included deter- lysis, and a phosphodiester backbone to passage 
across cell membranes (49). Passage to and accumulation in 2s mination of the Michaelis Menton 
the nuclear compartment of cultured cells was confirmed by 
confocal imaging of a fluorescein tagged decoy. Three 
decoys were synthesized: the active decoy, a random 
sequence control in which the six bases of the shear stress 
response element were scrambled, and a fluorescein conju- 
grown as above in 
conventional two-dimensional culture. Aliquots of cells 
exposed to Or active sequence decoy at 8o nm 
concentration were harvested at 2, 
exposure. 
and Vmax of the 
enzyme. The Michaelis Menton parameters were determined 
by automated curve fitting, 
EXAMPLE 13 
Culturing Renal Fibroblasts and Assay for Production of 
30 Erythropoietin gated form Of the decoy. Decoys were placed in the As renal fibroblasts are the of erythropoietin medium Of rat secreted into the circulation, renal fibroblasts were cultured. 
Freshly dissected rat  renal cortex was minced and 
collagenase\trypsin digested prior to removal of debris on a 
and 24 hours after 3s single discontinuous 5% albumin gradient. The mixture of 
rat renal cortical cells was placed into culture in DMEM\F12 
with 20% fetal bovine serum. After two weeks to encourage 
fibroblast overgrowth in the rich medium, fibroblast growth 
factor was added. The resultant culture had fibroblastic 
EXAMPLE 11 
Genetic Discovery Array 
A Of human 'Ortical grown in 'Onven- features in the culture flask and was inoculated into a high 
tional flask was and into a gas 40 aspect rotating vessel1 (HARV) for culture under increased 
Permeable bag and a rotating shear stress conditions. The cells aggregate on the beads and 
turning lateral vessel). After 8 days of culture on 5 mdml  slowly increasing their numbers. After 3 weeks growing the 
CYtodex-3 beads, cells were washed Once with ice cold fibroblasts in a HARV, erythropoietin was assayed in the cell 
phosphate buffered saline, the cells were then lysed and supernatant. The media were concentrated 15x and assayed 
MRNA was selected with biotinylated oligo(dT) then sepa- 4s via RIA. The media alone was also concentrated 15x as the 
rated with streptavidin paramagnetic particles (PolyATtract control. 
System 1000, Promega Madison, Wis.). 32P labeled cDNA 
32P dCTP. The cDNA probes were hybridized to identical so ropoietin 
Gene (Genome Inc. St. As hepatocytes are a source of erythropoietin secreted 
Louis, Mo.1. The Gene Discovery Array filters contain into the circulation, immortalized human hepatocyes were 
18,394 unique human genes from the 1.M.A.G.E. Chsor-  cultured under control and applied shear stress conditions. 
tium [LLNL](15) CDNA Libraries which are robotically The Hep3B cells were placed into culture in DMEM with 
arrayed on each of a pair of filter membranes. Gene expres- 10% fetal bovine serum in static flask culture. The resultant 
sion was then detected by phosphor imaging and analyzed ss culture was split, one half remaining in static flask culture 
using the Gene Discovery Software [Genome Systems] (50). and the other half was inoculated into a HARV for culture 
under increased shear stress conditions. The cells aggregated 
EXAMPLE 12 on the beads. After 24 hours growing the Hep3B cells in a 
HARV, erythropoietin was assayed in the cell supernatant. 
As the 1-a-hydroxylase enzyme has never been isolated or 60 The media were assayed by RIA. The static flask media was 
also assayed as the control. 
(55 m1 
EXAMPLE 14 
probes were then generated by transcription with Culturing Hapatocytes and Assay for Production of Eryth- 
Assay of 1-a-hydroxylase Activity 
cloned it is assayed functionally by the production of 
1,25-dihydroxy-vitamin D3 from ultrapure exogenous 
25-hydroxy vitamin D3. For each measurement, the classic 
Michaelis Menton kinetics of the enzyme are determined by 
assaying equal aliquots of renal cell aggregates in a curve of 65 
25-OH D3 substrate concentrations from 0.1 to 10 mgiml in 
6 steps. All incubations are performed in the presence of the 
EXAMPLE 15 
Shear Stress Response Elements Mediate Changes 
in Erythropoietin Gene Expression 
The immortal hepatic cell line, Hep3B, constitutively 
produces erythropoietin. The 5' promoter and 3' enhancer 
US 6,730,498 B3 
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regions of the gene contain putative shear stress response 
elements. The role of these elements in the enhancement of 
erythropoietin production in response to shear was tested by 
using integrated perfused rotating wall vessel culture to 
reintroduce graded shear. This protocol utilizes a library of 
promoters driving luciferase reporters genes, with various 
constructs lacking the putative shear stress response ele- 
ments. It also allows DNA footprinting analysis of the 
histones which bind the promoter and enhancer elements. 
EXAMPLE 16 
Results 
The proportion of proximal tubular cells in human renal 
cell fractions isolated by differential trypsinization was 
assayed using an entrapped fluogenic substrate for the 
proximal enzyme marker g-glutamyl-transferase (44). Flow 
cytometry analysis on a cell-by-cell basis showed the natural 
cell mixture in the human renal cortex to be 85+4%, n=4 
proximal tubular cells (FIG. lA,  left panel). Following 
differential trypsinization, and selection of the pure 
fractions, proximal tubular enrichments as high as 99+1% 
could be achieved (right panel). As reported in other 
systems, rotating wall vessels were conducive to vigorous 
cell growth, as evidenced by the high rates of glucose 
consumption assayed as 30 mgidl glucose/100,000 cellsiday. 
A cell doubling time of 4+3 days was assayed using Alamar 
blue in the rotating wall vessel compared to 4+2days in 
conventional culture A(n=4). 
The ultrastructure of cultures of pure proximal tubular 
cells or renal cortical cell mixtures of human kidneys were 
grown in rotating wall vessels for 16 days, and were 
examined by transmission electron microscopy (FIGS. 1B 
and IC). Quantitation of the number of microvilli present by 
counting random plates at the same magnification demon- 
strates not only that the rotating wall vessel induces 
microvillus formation, but co-culture with the normal mix of 
renal cortical cells increases the effect (Table 1). Normal 
cortical cell mix in conventional two-dimensional culture 
has 21 microvilli per field; “pure” proximal tubular culture 
in rotating wall vessel has 104 microvilli per field; and the 
normal cortical cell mix. in rotating wall vessel has 35 11 
microvilli per field. 
TABLE 1 
Human proximal tubular cells microvilli counted on transmission electron- 
micrographs of cells grown for 16 davs under various culture conditions 
% 
Proximal Microvilli 
Tubular Per 
Culture Conditions Markers Field 
conventional 2-D culture 85 2 1  
pure + culture in rotating wall vessel 99 10 4 
normal cortical cell mix in rotating wall vessel 85 3s 11 
To examine the expression of megalin and cubulin in renal 
cells in culture, there are advantages to using human cells 
instead of rat cells. Specifically, the rat sequences of megalin 
and cubulin have been cloned, while the human sequences 
have not, and the antisera recognizes the rat but not the 
human isoforms of these proteins. Hence, the natural mix- 
ture of cells in the rat renal cortex was placed into culture in 
rotating wall vessels, stirred fermentors, and traditional 
culture for analysis of protein expression. 
As the endosomal pathway has been implicated to play a 
central role in the function and pathophysiology of cubulin 
and megalin, entrapped endosomal markers were 
co-localized with receptor antibody binding. The ability of 
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flow cytometry to make simultaneous measurements of 
entrapped fluorescein dextran as an endosomal marker and 
antibody binding allows construction of three dimensional 
frequency histograms displaying entrapped fluorescein dex- 
tran fluorescence against antibody binding on horizontal 
axes and number of vesicles in each channel up out of the 
page (FIGS. 2A-2C). A control sample shows vesicles 
negative for fluorescein on the left and fluorescein contain- 
ing endosomes on the right (200 vesicles depicted, left 
panel). A control without fluorescein entrapped shows only 
the left population (not shown). Co localization of anti- 
cubulin binding demonstrates that all the fluorescein positive 
endosomes were positive for cubulin, while non-endosomal 
membranes could be subdivided into cubulin positive and 
negative populations. (middle panel). This pattern was 
repeated for anti-megalin binding in renal cortical cells 
(right panel) in culture. 
Next, analysis of protein expression in cultured cells by 
antibody binding used classic serial log dilution antibody 
curves. An increase in binding with a decrease in dilution is 
pathognomonic for specific antibody binding during flow 
cytometry analysis. Binding of anti-cubulin antisera to 
membrane vesicles prepared from renal cortical cells after 
16 days in culture, detected by the fluorescence of a phy- 
coerthyrein tagged secondary antibody, shows an almost two 
log increase in binding with antibody dilution (FIG. 2B). 
This increase in the cells grown in the rotating wall vessel 
(slow turning lateral vessel) is more than five times the 
expression seen in stirred fermentors. Similarly there was no 
detectable expression in the conventional cultures resulting 
in a flat line (not shown). Comparison of maximal binding 
of the anti-cubulin antibody to minimum taken to be the 
antibody dilution at which there is no further decline in 
signal with primary antibody dilution is shown in FIG. 2C. 
Binding of normal serum and minimal dilution of primary 
antisera were not detectably different. Binding curves for 
anti-megalin antiserum showed a similar pattern (not shown) 
but the peak binding was a little lower (FIG. 2C). Again 
stirred fermentor has much less expression than the rotating 
wall vessel (slow turning lateral vessel) and the conventional 
cell membranes have no detectable binding (not shown). 
To examine the proportion of proteins changing in the 
rotating wall vessel, two-dimensional gel SDS-PAGE analy- 
sis on cultures grown in the rotating wall vessel and bag 
controls were performed (FIG. 2B). The results shown in 
FIG. 2B demonstrates changes were in a selected group of 
proteins. 
To identify the genes changing during rotating wall vessel 
culture, differential display were performed. Differential 
display of expressed genes was compared in aliquots of the 
same cells grown in a 55 ml rotating wall vessel (slow 
turning lateral vessel) or conventional gas permeable 
2-dimensional bag controls. Differential display of copies of 
expressed genes were generated by polymerase chain reac- 
tion using random 25 mer primers and separated on a 6% 
DNA sequencing gel. Bands of different intensity between 
control and slow turning lateral vessel, representing differ- 
entially expressed genes, were identified by visual 
inspection, excised and reamplified using the same primers. 
Differential expression and transcript size were confirmed 
by Northern hybridization. PCR products were then sub- 
cloned into the pGEM-T vector and sequenced. Sequences 
were compared to the Genebank sequences using the 
BLAST search engine. One expressed gene which decreased 
in the slow turning lateral vessel (band D on gel, FIG. 3A) 
was identified as rat manganese-containing superoxide dis- 
mutase (98% match 142 of 144 nucleotides). Two genes 
US 6,730,498 B3 
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which increased in the slow turning lateral vessel, band A 
was identified as the interleukin-1 beta gene (100% match 
for 32 of 32 nucleotides) and Band B which corresponded to 
a 20 kB transcript on a Northern blot appears to be a 
unidentified gene that has a 76% homology to the mouse 
GABA transporter gene. 
To examine the genetic changes in specific genes, the 
expression of tissue specific epithelial cell markers and 
classic shear stress response dependent genes were exam- 
ined by RT-PCR (FIG. 3c). Several genes specific for renal 
proximal tubular epithelial cells, including megalin, cubulin, 
the extracellular calcium sensing receptor, and the microvil- 
lar structural protein villin, increase early in rotating wall 
vessel culture. Similarly there were dynamic time dependent 
changes in classic shear stress dependent genes including 
intercellular adhesion molecule 1 (ICAM) and vascular cell 
adhesion molecule (VCAM) (increased) and manganese 
dependent superoxide dismutase (suppressed). Many but not 
all of these changes were prolonged, as after 16 days in 
culture gene expression of megalin, ICAM, VCAM and the 
extracellular calcium sensing receptor were still elevated, 
while villin and manganese dependent superoxide dismutase 
were at control levels. Expression of control GADPH, 
b-actin and 18s genes did not change throughout the time 
course. 
To test for a role of a putative endothelial shear stress 
response element in these renal cortical cell changes, an 
antisense probe for the sequence was synthesized (FIG. 4A). 
A control probe had the active motif scrambled. Confocal 
imaging of a fluorescein conjugated form of the probe 
confirmed nuclear delivery of the probe (images not shown). 
Culture of rat renal cortical cells in 80 nm of the probe, 
resulted in a time dependent increase in magnesium depen- 
dent superoxide dismutase, but no change in villin gene 
expression (FIG. 4B). The control probe had no effect. 
In order to confirm the genetic responses to rotating wall 
vessel culture and the analysis with human cells, automated 
gene display analysis of expressed RNA was performed on 
human renal cortical cells grown in a control gas-permeable 
bag and the slow turning lateral vessel for 8 days (50). Of the 
more than 18,000 genes assayed a select group was again 
observed to change (FIG. 5).  In particular, vectored changes 
in all the classic shear stress response genes assayed by 
RT-PCR and differential display in rat cell culture were 
confirmed. A battery of tissue specific genes was increased 
including villin, angiotensin converting enzyme, parathyroid 
hormone receptor and sodium channels. Other physical 
force dependent genes such as heat shock proteins 27/28 
kDa and 70-2 changed, as did focal adhesion kinase, and a 
putative transcription factor for shear stress responses NF-kb 
changed. Fusion proteins such as synabtobrevin 2 mildly 
decreased gene expression, and clathrin light chains hugely 
increased gene expression. 
To determine whether renal cells grown in simulated 
microgravity have 1-a-hydroxylase activity, the l -a-  
hydroxylase activity of cell cultures were compared grown 
in traditional 2-D culture in gas permeable bags, and NASA 
rotating wall vessels. Both rat renal cells (Table 2) and 
human embryonic renal cells were assayed (Table 3). 
16 
TABLE 2 
The 1 a-hydroxylase activity of the various rat renal cell cultures detected 
as production of 1,ZS-diOH D3 S 
Volume of 
1,ZS-diOH D3 Supernatant 1,ZS-diOH D3 
Cell Sample concentration (pgiml) (ml) Production (pg) 
Boiled static <2, not detectable 7 ml Not detectable 
Boiled static <2, not detectable 7 ml Not detectable 
control I1 
Static control I <2, not detectable 7 ml Not detectable 
Static control I1 <2, not detectable 7 ml Not detectable 
Boiled rotating <2, not detectable SS ml Not detectable 
1s wall vessel 
Rotating wall 14.2 SS ml 781 
vessel 
10 control I 
The results shown in TABLE 2 indicate that rat renal cells 
20 show increased structural differentiation during culture in 
simulated microgravity conditions, and express much 
greater 1-a-hydroxylase activity than under conventional 
culture conditions. 
2s TABLE 3 
The 1 a-hydroxylase activity of the various human embryonic renal cell 
cultures detected as production of 1,ZS-diOH D3 
1,ZS-diOH D3 
Concentration Volume of 1,ZS-diOH D3 
Cell Sample (pgiml) Supernatant (ml) Production (pg) 
Boiled static control 8.2 10 82 
Static control 14.6 10 146 
Rotating wall vessel 24.8 5s 1364 
30 
3s  
TABLE 3 indicates that human embryonic kidney cells 
show increased structural differentiation during culture in 
simulated microgravity conditions, and express 10 fold 
greater 1-a-hydroxylase activity than under conventional 
40 culture conditions. 
TABLE 4 
Renal fibroblasts cell supernatant erythropoietin assay 
Condition Erythropoietin (muiml) 4s  
Shear stress culture 
Control media conc 1SX 
1.8 
0.23 
so 
TABLE 5 
Hepatocytes cell supernatant erythropoietin assay 
Condition Erythropoietin (muiml) 
Shear stress culture 141.7 muil x 106 cells 
Control static flask undetectable 
5s 
Results of cell supernatant erythropoietin assay from renal 
60 fibroblasts and hepatocytes culture were shown in Table 4 
and Table 5, respectively. The results shown in TABLES 4 
and 5 indicate erythropoietin production was increased in 
both renal and hepatic cells during graded gravitational 
sedimentation shear. 
Erythropoietin has the classic shear stress response ele- 
ments in the promoter and enhancer regions which control 
expression of its gene. The results shown in Tables 4 and 5 
65 
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also indicate that the expression of the erythropoietin gene 
was upregulated by those shear stress response elements 
during graded gravitational sedimentation shear in the ves- 
sel. 
EXAMPLE 17 
Discussion 
Rotating wall vessels have been used by other investiga- 
tors as “simulated microgravity”. The present invention 
contends that gravity is still active, and that in a rotating wall 
vessel gravity is balanced by equal and opposite sedimen- 
18 
receptor for vitamin-B12 intrinsic factor (52). Although 
these receptors are expressed by transformed placental cells 
in culture (9, 43), there is currently no renal model express- 
ing these markers for toxicology investigations (53). Rotat- 
s ing wall culture provides a fresh approach to expression of 
renal specific markers in culture for study on the 
pharmacology, biochemistry and toxicology which define 
the unique properties and sensitivities of renal epithelial 
cells. 
The second pattern of change is represented by villin. i o  
tational shear stress. A centrifugal force due to spinning the Message for the microvilli protein villin increases in the 
cells, quantitatively much smaller than gravity, is also rotating wall vessel in the first day of culture, and soon 
present and offset by equal and opposite sedimentational reformation of microvilli was observed. A decoy matching. 
shear stress. Thus, the present invention presents a new the nuclear binding motif of a putative shear stress response 
concept that rotating wall vessels provide this new balance is element failed to induce similar changes. Although the 
of forces, including application of sedimentational shear, promoter for villin has not been cloned, this suggests the 
rather than microgravity. changes in villin were induced by other transcription factors 
The rotating wall vessel bioreactor provides quiescent which may be due to shear stress or other stimuli in the 
co-localization of dissimilar cell types (1,46), mass transfer bioreactor. Villin is also restricted to brush border mem- 
rates that accommodate molecular scaffolding and a micro- 20 branes such as renal proximal tubular cells, or colonic villi 
environment that includes growth factors (1, 46). Engineer- (54-55). The observed increases in villin message resolved 
ing analysis of the forces active in the vessel is complex (1, after 16 days of rotating wall vessel culture. 
5-7). This study provides the first evidence for the cell Magnesium dependent superoxide dismutase represents a 
biological mechanisms by which the vessel induces changes third pattern of response: a mitochondrial enzyme, ubiqui- 
in tissue specific gene and protein expression. zs tous is distribution, modulated by the classic shear stress 
There are two possible explanations why the rotating wall response element in endothelial cells (56-57). Magnesium 
vessel induces an order of magnitude more expression of the dependent superoxide dismutase message decreased early in 
renal toxin receptors cubulin and megalin than stirred fer- the first day of rotating wall vessel culture, and this was 
mentor culture. First, there are significant differences in the persistent after 16 days in culture. These changes were 
degree of shear stress induced. The rotating wall vessel 30 confirmed when magnesium dependent superoxide dismu- 
induces 0.5-1.0 dynesicm2 shear stress (l), while stirred tase was identified as suppressed in the differential display 
fermentors induce 2-40 dynesicm2 depending on design and analysis of gene changes, and Northern blot confirmation 
rotation speed (1, 5, 46). This degree of stress damages or was performed. Adecoy for the classic shear stress response 
kills most epithelial cells (1,5,46). Second, impeller trauma element induced an increase in magnesium dependent super- 
in the stirred fermentor, is absent in the rotating wall vessel. 3s oxide dismutase (MnSOD), which indicates that similar 
This explains why there was far more cubulin and megalin changes to the rotating wall vessel can be induced by the use 
induced in renal cultures in rotating wall vessel culture than of genetic decoys. Thus, the biological process of genetic 
a stirred fermentor, and both receptors were not detectable in induction by defined shear stress elements can be produced 
conventional 2-dimensional culture. by multiple means including genetic decoys or use of the 
Rotating wall vessel culture induced changes in a select 40 rotating wall vessel. Other shear stress response element 
set of genes, as evidenced by the genetic differential display dependent genes, specifically, intercellular adhesion mol- 
gels and 2-dimensional protein gel analysis. For example, ecule l (ICAM) and vascular cell adhesion molecule 
erythropoietin production is controlled by a shear stress (VCAM) had changes in the rotating wall vessel opposite to 
element which mediates changes observed during graded magnesium dependent superoxide dismutase, mirroring 
gravitation sedimentation shear. 1-a-hydroxylase activity is 4s observations made during flow induced stress in endothelial 
maintained and increased in both renal cortical epithelial cells (56-57). This provides three lines of evidence consis- 
cells and human embryonic kidney cells, wherein the induc- tent with a role for shear stress as one mediator of genetic 
tion of the enzyme (1-a-hydroxylase) converts 25-hydroxy- changes induced in the rotating wall vessel. 
vitamin D3 to the active 1, 25-dihydroxy-vitamin D3 form. Differential display of the genes activated and deactivated 
The present invention is the first demonstration of a process SO under rotating wall vessel culture conditions showed rotat- 
for production of molecules including hormones and other ing wall vessel culture was associated with decreased 
biomolecules induced by shear stress and other forces. The expression of manganese dependent superoxide dismutase 
mechanistic information can be interpreted from knowledge mRNA and increased expression of interleukin-1 b gene 
of the pattern of response and distribution of certain gene MRNA. This greatly extends and brings together previous 
products. ss observations on the interactions of stress, manganese depen- 
Megalin and cubulin represent the first pattern of change, dent superoxide dismutase expression and interleukin-1. 
as these proteins are restricted in distribution to renal Topper et al. reported an oppositely directed effect, i.e., 
cortical tubular epithelial cells. The increase in megalin differential display of vascular endothelial cells exposed to 
mRNA and protein, and cubulin protein expression is there- high stress demonstrates increased manganese dependent 
fore unequivocal evidence for changes in the epithelial cells. 60 superoxide dismutase gene expression (57). Other direct 
This provides an important new tool for studies of nephro- evidence links superoxide dismutase and interleukin-1 as 
toxicity. Long suspected to play a role in renal toxicity, the increases in manganese superoxide dismutase levels and 
tissue restricted giant glycoprotein receptors megalin and decreases in interleukin-1 levels in HT-1080 fibrosarcoma 
cubulin, have recently been shown to be receptors for cells (58). In more indirect evidence overexpression of 
common nephrotoxins. Megalin is a receptor for polybasic 65 mitochondrial manganese superoxide dismutase promotes 
drugs such as the aminoglycoside antibiotic gentamicin (48) the survival of tumor cells exposed to interleukin-1 (59). The 
and vitamin D binding protein (51), and cubulin is the present study provides direct evidence that modest shear 
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stress decreases magnesium dependent superoxide dismu- 
tase in association with an inverse effect on interleukin-1. 
The data here demonstrates internal consistency. The 
changes in magnesium dependent superoxide dismutase 
were observed on differential display, confirmed by North- 
ern blot analysis, and matched responses were detected by 
RT-PCR. Megalin demonstrated matched changes in 
RT-PCR gene and protein expression. Changes in villin 
observed by RT-PCR were associated with dramatic refor- 
mation of microvilli, in which villin is a major structural 
protein. Although semi-quantitative RT-PCR is prone to 
inherent variation due to the massive amplification of 
signals, the use of multiple controls which remain 
unchanged (b-actin, GAPDH and MS), and experimental 
confirmation that reactions were linearly related to cDNA 
concentration, minimizes these problems. The internally 
consistent findings by other methods strongly suggests this 
RT-PCR data is valid. 
Study of the mechanisms of action of the rotating wall 
vessel to induce gene and protein expression during cell 
culture has been hampered by nomenclature. First, the 
attachment of the moniker “simulated microgravity”, based 
on engineering analysis of boundary conditions, clouds 
intuitive analysis of the cell biology as there is no cellular 
equivalent for this term (1,6-7). Similarly the reduced shear 
stress in the rotating wall vessel compared to stirred fer- 
mentors leads to the term “reduced shear stress culture” (l) ,  
whereas there is increased shear stress compared to conven- 
tional 2-dimensional culture (1, 5). As cell aggregates 
remain suspended in the rotating wall culture vessels, grav- 
ity is balanced by an equal and opposite force. Engineering 
arguments on the relative contributions of fluid shear, drag, 
centrifugal force, coriolus motion, and tangential gravity- 
induced sedimentation are themselves tangential to the cell 
biology. Several lines of evidence are documented that shear 
stress responses are one of the component of the biological 
response. This opens the door for analysis of other biological 
response mediators in the vessels, and investigation as to 
whether unloading of gravity plays as big a role as the 
oppositely directed balancing forces. 
Using the rotating wall vessel as a tool, data here provide 
the first evidence that shear stress response elements, which 
modulate gene expression in endothelial cells, are also 
active in epithelial cells, although other investigators failed 
to see an effect of shear stress on epithelial cells. The present 
invention demonstrates that epithelial cells have shear stress 
response elements and change gene expression in response 
to physical forces including but not limited to sedimenta- 
tional shear stress. As the rotating wall vessel gains popu- 
larity as a clinical tool to produce hormonal implants it is 
desirable to understand mechanisms by which it induces 
genetic changes (10, 60), if necessary to prolong the useful 
life of implants. Several lines of evidence are provided that 
shear stress response elements are the first mechanism 
identified by which the rotating wall vessel induces genetic 
changes. Using a putative endothelial cell shear stress 
response element binding site as a decoy, the role of this 
sequence in the regulation of selected genes in epithelial 
cells was validated. However, many of the changes observed 
in the rotating wall vessel are independent of this response 
element. It remains to define other genetic response ele- 
ments modulated during rotating wall vessel culture, and 
whether the induced changes are secondary to the balancing 
forces, or primarily related to unloading gravity. 
20 
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the scope of the claims. 
SEQUENCE LISTING 
(1) GENERAL INFORMATION: 
(iii)NUMBER OF SEQUENCES: 1 
(2)INFORMATION FOR SEQ ID NO: 1 
(i)SEQUENCE CHARACTERISTICS: 
(A)LENGTH: 22 bp 
(B)TYPE: nucleic acid 
(C)STRANDEDNESS: single-stranded 
(D)TOPOLOGY: linear 
(ii)MOLECULE TYPE: 
(A)DESCRIPTION: cDNA to mRNA 
(iii)HYPOTHETICAL: no 
(iv)ANTISENSE: yes 
(v)FRAGMENT TYPE: 
(vi)ORIGINAL SOURCE: 
(vii)IMMEDIATE SOURCE: 
(viii)POSITION IN GENOME: 
(ix)FEATURE: 
(x)PUBLICATION INFORMATION: 
(xi)SEQUENCE DESCRIPTI0N:SEQ ID NO: 1: 
CTGAGACCGA TATCGGTCTC AG 22 
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40 What is claimed is: 
1. A method of producing a biomolecule in a bioreactor 
under simulated microgravity culture conditions comprising 
the steps Of: 
selecting mammalian cells for cell culture wherein said 
cells are capable of producing at least one functional 
biomolecule selected from the group consisting of 
functional proteins, non-peptide hormones, vitamins 
and mixtures thereof; 
into the cell culture; 
containing a culture media and a culture matrix; 
lated micro gravity culture conditions; and 
by the cell culture. 
J c1in Invest, 99, 2317-22,1997 
4s 
58' A, et Bioi Chem271(31):18898-18903, so isolating the selected mammalian cells for introduction 
1996. 
placing the mammalian cells into a rotating wall vessel 59. Hibose K, et al., FASEB J 7:361-368, 1993. 60. Soon-Shiong P, et al., The Lancet 343:950-951, 1994. 
Any patents or publications mentioned in this specifica- 
producing three dimensional cell aggregates under simu- tion are indicative of the levels of those skilled in the art to 
which the invention pertains. These patents and publications separating at least one functional biomolecule expressed are herein incorporated by reference to the same extent as if 
each individual publication was specifically and individually 2, The method of producing a biomolecule in a bioreactor 
under simulated microgravity culture conditions of claim 1 indicated to be incorporated by reference. 
present invention is well adapted to carry out the objects and from a selected from the group consisting of lysed 
obtain the ends and advantages mentioned, as well as those cells, the culture media and mixtures thereof, 
inherent therein. The Present examples along with the 3. The method of producing a biomolecule in a bioreactor 
methods, Procedures, treatments, molecules, and specific under simulated microgravity culture conditions and detect- 
compounds described herein are presently representative of 65 ing their production of claim 1 wherein the biomolecule is 
preferred embodiments, are exemplary, and are not intended selected from the group consisting of a hormone, a toxin 
as limitations on the scope of the invention. Changes therein receptor and a shear stress dependent functional biomolecule 
5s 
One in the art appreciate that the 60 further comprising separating the functional biomolecule 
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not associated with a degenerative cell process and isolating 
the selected functional biomolecule. 
4. The method of producing a biomolecule in a bioreactor 
under simulated microgravity culture conditions of claim 1 
wherein the functional biomolecule is selected from the 
group consisting of magnesium dependent superoxide 
dismutase, nitric synthase, c-fos, c-jun, platelet derived 
growth factor-b, transforming growth factor-b, tissue-type 
plasminogen activator, monocyte chemotactic protein-1, 
megalin, cubulin, erythropoietin 1-a-hydroxylase and 1,25- 
dihydroxy-vitamin D 3. 
5. The method of producing a biomolecule in a bioreactor 
under simulated microgravity culture conditions of claim 1 
wherein said mammalian cells are selected from the group 
consisting of epithelial cells, endothelial cells and mixtures 
thereof capable of producing functional biomolecules. 
6. The method of producing a biomolecule in a bioreactor 
under mulated microgravity culture conditions of claim 1, 
wherein said culture matrix is micro carrier beads. 
7. The method of producing a biomolecule in a bioreactor 
under simulated microgravity culture conditions of claim 1 
wherein said mammalian cells are organ cells capable of 
producing functional biomolecules selected from the group 
consisting of renal cortical cells, hepatocytes, pancreatic 
islets, renal interstitial cells, renal fibroblast cells, parathy- 
roid cells, thyroid cells, pituitary cells, ovarian cells and 
testicular cells. 
8. The method of producing a biomolecule in a bioreactor 
under simulated microgravity culture conditions of claim 5 
wherein the functional biomolecules are suitable for thera- 
peutic use. 
9. The method of producing biomolecules in a bioreactor 
under simulated microgravity culture conditions of claim 7 
wherein the functional biomolecules are suitable for thera- 
peutic use. 
10. The method of producing a biomolecule in a biore- 
actor under simulated microgravity culture conditions of 
claim 5 wherein the mammalian cells are human cells. 
11. The method of producing a biomolecule in a biore- 
actor under simulated microgravity culture conditions of 
claim 5 wherein the organ cells are human organ cells. 
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12. The method of producing biomolecules in a bioreactor 
under simulated microgravity culture conditions of claim 1 
further comprising the steps o f  
selecting mammalian cells capable of producing erythro- 
culturing the mammalian cells under conditions to pro- 
collecting the culture media and cells; and 
separating the erythropoietin from the source consisting 
of the group of culture media, lysed cells and mixtures 
thereof. 
13. The method of claim 12 further purifying erythropoi- 
etin wherein the erythropoietin is suitable for human thera- 
14. The method of producing a biomolecule in a biore- 
actor under simulated microgravity culture conditions of 
claim 1 further comprising the steps of  
selecting mammal cells capable of producing 1,25- 
culturing the cells under conditions to produce 1,25- 
collecting the cells; 
2s lysing the cells; and 
separating the 1,25-dihydroxy-vitamin D 3. 
15. The method of claim 14 of producing and purifying I, 
25-dihydroxy-vitamin D 3 in a bioreactor under simulated 
microgravity culture conditions wherein the 1,25- 
30 dihydroxy-vitamin D 3 is suitable for human therapeutic 
use. 
16. The method of producing a biomolecule in a biore- 
actor under simulated microgravity culture conditions of 
claim 1 wherein the isolated functional biomolecules are 
17. The method of producing a biomolecule in a biore- 
actor under simulated microgravity culture conditions of 
claim 1 wherein the functional biomolecules are suitable for 
diagnostic use. 
poietin; 
duce erythropoietin; 
i o  
is peutic use. 
20 dihydroxy-vitamin D 3; 
dihydroxy-vitamin D 3; 
3s suitable for therapeutic use. 
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